Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.
days to go:
Expired
investment:
£500,000
3DUserNet is an online portal for viewing and collaborating on 3D data projects. Its SaaS platform enables team members in engineering and construction companies to store, view, navigate and collaborate online, through any modern browser or device, without the need for installed software. The company has been working with sectors such as surveying, policing, civil engineering, security, road safety, and defence. Since its inception, it has added multiple measurement tools including clip boxes, line of sight, checkpoint tool, and slope tool on its platform. The company is seeking an investment of up to £400,000, at a pre-money valuation of £1.6 million under which it is offering investors making up the first £200,000 a discounted share price of £3.4733. Investors joining in for the remaining £200,000 thereafter will purchase a share for £4.6622. The funds raised will be used for further platform development, sales and marketing, and working capital.
days to go:
Expired
investment:
Withheld
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go:
Expired
investment:
Withheld
ShareOptic automatically assesses each share regardless of the device or cloud service being used in near real-time. Data shares are checked against dynamic blacklist and sanction lists and immediately and automatically blocked. ShareOptic wraps all cloud technology that enables data sharing, placing controls around the data so the user can be safe in the knowledge that ShareOptic is tracking who the data is shared with.
days to go:
Expired
investment:
£5,909
Ever Insight (EI) offers professional analytics services catered to a customer's needs. The company platform draws valuable insights from data ensuring that business managers can make efficient decisions. EI specialises in three main verticals namely, Predictive Learning Analytics (PLA), Financial Analytics (FA) and HR Analytics (HA). EI's current mission is to deliver an innovative and supportive analytics system to institutions that facilitate learning and eliminate roadblocks to student success. Its team has already developed the software and implemented it in India, but the company needs further refinement and adaptation to suit the UK educational market requirements. It will use the investment to get its Start-up visa approved and establish its business at different verticals.
days to go:
Expired
investment:
Withheld
Wise Analytics Group uses data to help companies, consumers and brands make better connections and more benefitial choices. They are a leader in terms of media analytics in the beauty sector, using a range of tools, technology and experience to create a product, market and consumer insight. Wise Analytics group have clients such as L'Oreal and Estee lauder. They are now looking to expand into other locations.
days to go:
Expired
investment:
Withheld
whatimpact is a social impact technology entity that uses AI and specific reporting tools to match charities and social enterprises, termed 'Recipients', with donor companies and grant-makers, termed 'Supporters' to ensure efficiency and transparency in Corporate Social Responsibility (CSR) and grant-making. whatimpact aspires to become a contender in the CSR segment that is estimated to be worth over £76 billion in reputational value to UK corporates. The business has onboarded 20 companies and 120 charities/Social Enterprises in Q1 2021 including EY, Brewin Dolphin, and Engie. whatimpact has a further 500 charities/social enterprises and 45 corporates in the pipeline. Its subscriptions range from £100/month to £2,000/month. It will use the investment to develop its algorithm and datasets, engage in customer acquisition, and build its leadership team.
days to go:
Expired
investment:
£375,002
Simply get results limited are a universal data analytics solution, improving financial performance through people. They have established a client portfolio of household names and are profitable with over £400k of revenue. They save organisations tens of millions of pounds using their proprietary software and unique algorithms to find patterns and trends to present unseen opportunities.
days to go:
Expired
investment:
£205,000
GemTrax.IO's GemTrax Mobile App provides buyers and sellers of precious stones a comprehensive set of logical, physical, and administrative protocols. Powered by blockchain technology, the app ensures informational integrity while providing an immutable and easily audited record of the material's journey from mine to sellers. GemTrax's strategy for capturing market share and increasing user base includes targeting specific upstream gemstone supply chain stakeholders in key CAHRA markets such as Rwanda, Uganda, and Tanzania. With the proceeds, the company will purchase rough diamonds in the DRC, issue certificates of origin, sell the diamonds, and complete development of the mobile app.
days to go:
Expired
investment:
£773
